ReviewHeart rhythm2026
Gene-elusive arrhythmogenic cardiomyopathy: Roles of sports, inflammation, and beyond.
Review in Heart rhythm, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Yield of Family Screening in Arrhythmogenic Right Ventricular Cardiomyopathy Without a Validated Genetic Cause.Circulation. Arrhythmia and electrophysiology · 2026Article
- Lipid Metabolism as a Therapeutic Target in Arrhythmogenic Cardiomyopathy: Emerging Therapeutic Implications of Lipid-Lowering Therapy.Reviews in cardiovascular medicine · 2026Review
- Electromagnetic interference during epicardial ablation in a patient with an extravascular implantable cardioverter-defibrillator and arrhythmogenic right ventricular cardiomyopathy: a case report.European heart journal. Case reports · 2026Article
- Autoantibody Profiling in Cardiomyopathies: Toward Immune-Guided Risk Stratification and Therapy.Journal of clinical medicine · 2026Review
- [Exercise in cardiomyopathies: updated evaluation, risk stratification, and clinical prescription].Archivos peruanos de cardiologia y cirugia cardiovascularReview
Corrections and comments
- AssociatedPublication
- AssociatedPublication
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Arrhythmogenic cardiomyopathy (ACM) represents a leading cause of sudden cardiac death in young adults and in athletes. Although inherited cases typically involve genetic variants in desmosomal proteins, impairing cardiac tissue's capacity to withstand mechanical stress, approximately one-third of patients with ACM harbor no identifiable genetic variant and are classified as gene elusive. Even if some gene-elusive cases may be caused by yet undiscovered variants, the striking observation that gene-elusive ACM predominantly affects high-level endurance athletes without familial disease has generated the concept of exercise-induced ACM, a form of desmosomal damage caused by excessive endurance exercise in the absence of a causal variant, most probably in the presence of a polygenic predisposition. Through mechanical stress and transcriptional pathways, endurance exercise may prompt the upregulation of desmosomal proteins before reaching a threshold where chronic stress leads to inflammatory and autoimmune reactions, further destabilizing the intercalated disc and exacerbating cardiomyocyte damage. According to the current understanding, inflammatory and mechanical effects of exercise may thus act synergistically, accelerating the transition from physiological adaptations to pathologic remodeling with irreversible structural and arrhythmic manifestations. This comprehensive review examines the evolving understanding of gene-elusive ACM, exploring mechanical and transcriptional explanations and inflammatory triggers to autoimmune responses, while addressing the critical clinical challenge of differentiating pathologic remodeling from physiological athletic adaptation.
Indexed as
Identifiers
41077366What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.